APC anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_APC_090507
C57BL/6 mouse splenocytes stained with 30-F11 APC
  • 30-F11_APC_090507
    C57BL/6 mouse splenocytes stained with 30-F11 APC
See APC spectral data
Cat # Size Price Quantity Check Availability Save
103111 25 µg $30.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103112 100 µg $85.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical data sheet

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6 and Western blotting7. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
Product Citations
  1. An J,et al. 2017. Sci Rep.. 10.1038/s41598-017-13629-0. PubMed
  2. Feng J,et al. 2017. Nat Commun. . 10.1038/s41467-017-01056-8. PubMed
  3. Pal B, et al. 2017. Nat Commun.. 10.1038/s41467-017-01560-x. PubMed
  4. Zheng B, et al. 2018. J Hematol Oncol. 11:16. PubMed
  5. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  6. Kabir AU, et al. 2018. JCI Insight. 3. PubMed
  7. Gavin KM, et al. 2018. Front Endocrinol (Lausanne). 9:276. PubMed
  8. Shavit Stein E, et al. 2018. Neural Plast. 2018:7692182. PubMed
  9. Wunderlich CM, et al. 2018. Nat Commun. 9:1646. PubMed
  10. Wang L, et al. 2018. Bone Res. 6:22. PubMed
  11. Yuan Z, et al. 2018. Emerg Microbes Infect. 7:59. PubMed
  12. Echevarría-Vargas IM, et al. 2018. EMBO Mol Med. 10:e8446. PubMed
  13. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  14. Cha JH et al. 2018. Molecular cell. 71(4):606-620 . PubMed
  15. Haimon Z et al. 2018. Nature immunology. 19(6):636-644 . PubMed
  16. Liu L et al. 2018. Cell stem cell. 23(4):544-556 . PubMed
  17. Sarshad AA, et al. 2018. Mol Cell. 71:1040. PubMed
  18. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  19. Shi R, et al. 2019. J Cancer. 10:367. PubMed
  20. Qiao S, et al. 2019. J Neuroinflammation. 16:4. PubMed
  21. Chiche A, et al. 2019. Breast Cancer Res. 21:13. PubMed
  22. Gao Q, et al. 2019. J Exp Med. 216:688. PubMed
  23. Xiao X, et al. 2019. Cell Discov. 5:2. PubMed
  24. Peltzer N, et al. 2018. Nature. 557:112. PubMed
  25. Piotrowski AF, et al. 2018. Oncoimmunology. 7:e1445951. PubMed
  26. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  27. Cao Y, et al. 2019. Nat Commun. 10:1280. PubMed
  28. Wosczyna MN et al. 2019. Cell Rep. 27(7):2029-2035 . PubMed
  29. Maston LD, et al. 2017. Am J Physiol Lung Cell Mol Physiol. 312:L609. PubMed
  30. Karlen SJ, et al. 2018. J Neuroinflammation. 15:344. PubMed
  31. Bresson L, et al. 2018. Development. 145. PubMed
  32. Toyama K, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1392. PubMed
  33. De S, et al. 2018. Development. 145. PubMed
  34. Charmsaz S, et al. 2017. Leukemia. 31:1779. PubMed
  35. Bradley KC, et al. 2019. Cell Rep. 28:245. PubMed
  36. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  37. Tu WL, et al. 2018. Am J Pathol. 188:2688. PubMed
  38. Ouadah Y, et al. 2019. Cell. 179:403. PubMed
  39. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  40. Carmody C et al. 2019. Endocrinology. 160(5):1205-1222 . PubMed
  41. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  42. Usmani SM et al. 2019. Cell host & microbe. 25(1):73-86 . PubMed
  43. Testini C, et al. 2019. EMBO Rep. 20:e47845. PubMed
  44. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  45. Jin X, et al. 2019. Mol Cell. 73:22:00. PubMed
  46. Fu NY, et al. 2018. Dev Cell. 47:629. PubMed
  47. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  48. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  49. Oetjen LK et al. 2017. Cell. 171(1):217-228 . PubMed
  50. Zasłona Z, et al. 2017. Am J Physiol Lung Cell Mol Physiol. 312:L855. PubMed
  51. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  52. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  53. Mourao L, et al. 2019. Sci Rep. 0.991666667. PubMed
  54. Romagnoli M, et al. 2019. Stem Cell Reports. 1.077083333. PubMed
  55. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  56. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  57. Chen PY, et al. 2019. Nat Metab. 0.675. PubMed
  58. Herting CJ, et al. 2019. Brain. 142:3834. PubMed
  59. Sroor HM, et al. 2019. Sci Rep. 9:20217. PubMed
  60. Dudek KA, et al. 2020. Proc Natl Acad Sci U S A. 117:3326. PubMed
  61. Hou M, et al. 2020. Stem Cell Res Ther. 11:55. PubMed
  62. Kaur A, et al. 2019. Cancer Discov. 9:64. PubMed
  63. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  64. Liu D, et al. 2020. Front Pharmacol. 11:204. PubMed
  65. Lu Y, et al. 2020. Immunity. 52:782. PubMed
  66. Strickley JD, et al. 2019. Nature. 575:519. PubMed
  67. Qu Y, et al. 2020. Cell Reports. 32(1):107873. PubMed
  68. Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed
  69. Cai B, et al. 2020. Cell Metabolism. 31(2):406-421.e7.. PubMed
  70. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  71. Hays C, et al. 2020. eLife. 8:e48772.. PubMed
  72. Yeo SK, et al. 2020. eLife. 9:e58810.. PubMed
  73. Engelbrecht E, et al. 2020. eLife. 9:e52690.. PubMed
  74. Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed
  75. Zhou G, et al. 2019. FASEB J. 33:11396. PubMed
  76. Sambasivan R, et al. 2011. Development. 138:3647. PubMed
  77. Pelletier A, et al. 2012. J Immunol. 188:5561. PubMed
  78. Kang I, et al. 2012. Blood. 119:3295. PubMed
  79. Lafkas D, et al. 2013. J Cell Biol. 203:47. PubMed
  80. Wang C, et al. 2011. Hepatology. 55:108. PubMed
  81. Roberts L, et al. 2014. Infect Immun . 82:2504. PubMed
  82. Garcia-Bonilla L, et al. 2014. J Immunol. 193:2531. PubMed
  83. Hyatt L, et al. 2014. PLoS One. 9:109072. PubMed
  84. Ding X, et al. 2015. J Immunol. 194:4251. PubMed
  85. Elias S, et al. 2015. PLoS Biol. 13:1002142. PubMed
  86. Seki T, et al. 2015. J Biochem. 158: 485 - 495. PubMed
  87. Wang L, et al. 2015. Cancer Immunol Res. 3: 1030-1041. PubMed
  88. Jiang Y, et al. 2015. MBio. 6: e01426-15. PubMed
  89. Garcia-Bonilla L, et al. 2015. J Neurosci. 35: 14783 - 14793. PubMed
  90. Liu L, et al. 2015. Neurol Neuroimmunol Neuroinflamm. 2: 174. PubMed
  91. Sim S, et al. 2016. PLoS One. 11: 0152485. PubMed
  92. Mangum L, et al. 2016. Toxicol Sci. 150: 169 - 177. PubMed
  93. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  94. Ahmed M, et al. 2016. Development. 143: 1663 - 1673. PubMed
  95. Eastman A, et al. 2016. J Immunol . 194: 5999-6010. PubMed
  96. Yuan Z, et al. 2016. J Virol. 90: 7728 - 7739. PubMed
  97. Wong J, et al. 2016. Sci Signal. 9: ra103. PubMed
  98. Chiche A, et al. 2016. Oncogene. 10.1038/onc.2016.396. PubMed
  99. Mueller A, et al. 2016. Nature. 540:276-279. PubMed
  100. Vaas M, et al. 2016. J Cereb Blood Flow Metab. 10.1177/0271678X16676825. PubMed
  101. Mizuno T, et al. 2017. Sci Rep. 7:42714. PubMed
  102. Paiva-Oliveira E, et al. 2017. Histochem Cell Biol. 10.1007/s00418-017-1556-6. PubMed
  103. Díaz NM, et al. 2020. Invest Ophthalmol Vis Sci. 61:37:00. PubMed
  104. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  105. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  106. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  107. Cayre S, et al. 2020. Development. 147:00:00. PubMed
  108. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
  109. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  110. Jaiswal AK, et al. 2020. Immunobiology. 225:151956. PubMed
  111. Koh BI, et al. 2020. Nat Commun. 3.143055556. PubMed
  112. Barberio AE, et al. 2020. ACS Nano. 14:11238. PubMed
  113. Perry JL, et al. 2020. ACS Nano. 5.583333333. PubMed
  114. Strunz M, et al. 2020. Nat Commun. 2.929861111. PubMed
  115. Taya M, et al. 2020. Endocr Relat Cancer. 27:261. PubMed
  116. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
  117. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  118. Dawson CA, et al. 2021. Nature Protocols. 16(4):1907-1935. PubMed
  119. Amouyal C, et al. 2020. EBioMedicine. 58:102895. PubMed
  120. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  121. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  122. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  123. Bagati A, et al. 2020. Cancer Cell. 39(1):54-67.e9. PubMed
  124. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  125. Almada AE, et al. 2021. Cell Reports. 34(4):108656. PubMed
  126. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  127. Deng P, et al. 2021. Cell Stem Cell. 28(6):1057-1073.e7. PubMed
  128. Ma S, et al. 2021. Cell Reports. 34(6):108726. PubMed
  129. Yang Y, et al. 2021. Cell Reports. 34(10):108822. PubMed
  130. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  131. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  132. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  133. Wosczyna MN, et al. 2021. Cell Stem Cell. 28(7):1323-1334.e8. PubMed
  134. Bravo JI, et al. 2021. STAR Protocols. 2(2):100406. PubMed
  135. Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed
  136. Ankawa R, et al. 2021. Developmental Cell. . PubMed
  137. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  138. Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed
  139. Larouche JA, et al. 2021. eLife. 0.416666666666667. PubMed
  140. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  141. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  142. Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed
  143. Yanagida K, et al. 2020. Dev Cell. 779:52. PubMed
  144. Motoyama S, et al. 2020. Cells. :9. PubMed
  145. Lim JT, et al. 2020. Mol Cancer Ther. 1809:19. PubMed
  146. Penkert RR, et al. 2020. Obesity (Silver Spring). 1631:28. PubMed
  147. Ren D, et al. 2020. Am J Cancer Res. 2851:10. PubMed
  148. Mori A, et al. 2021. Cells. :10. PubMed
  149. Xi W, et al. 2021. Stem Cell Res Ther. 167:12. PubMed
  150. Jia Q, et al. 2021. Theranostics. 4699:11. PubMed
  151. Saber M, et al. 2020. Eur J Neurosci. 52:2791. PubMed
  152. Zhang Y, et al. 2020. Cancer Res. 80:3345. PubMed
  153. Wu J, et al. 2020. Immunity. 53:115. PubMed
  154. Shcherbina A, et al. 2020. Cell Rep. 32:107964. PubMed
  155. Maller O, et al. 2020. Nat Mater. 20:548. PubMed
  156. Jiang Z, et al. 2021. J Clin Invest. 131: . PubMed
  157. Oliva Chávez AS, et al. 2021. Nat Commun. 12:3696. PubMed
  158. Pal B, et al. 2021. Breast Cancer Res. 23:69. PubMed
RRID
AB_312976 (BioLegend Cat. No. 103111)
AB_312977 (BioLegend Cat. No. 103112)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 05/14/2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account